HPC cell infusion ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 45 | Eosinophilic granulomatosis with Polyangiitis | 1 |
45. Eosinophilic granulomatosis with Polyangiitis
Clinical trials : 28 / Drugs : 42 - (DrugBank : 18) / Drug target genes : 18 - Drug target pathways : 100
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02728271 (ClinicalTrials.gov) | April 2016 | 14/3/2016 | Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome | A Pilot Study of Immuno-ablation With Chemoimmunoradiation Followed by Autologous Hematopoietic Progenitor Cell (HPC) Transplant for Adult Subjects With Churg-Strauss Syndrome | Churg-Strauss Syndrome | Biological: HPC cell infusion | Mounzer Agha | NULL | Terminated | 18 Years | 60 Years | All | 1 | Early Phase 1 | NULL |